Showing results (1181-1190 of 1,194) with videos related to
Sort By:
Pageof 120
JCI Insight|June 15, 2017
An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibitionEdouard Forcade, Katelyn Paz, Ryan Flynn, et al.Head & Neck|May 17, 2014
Measuring quality of life in patients with head and neck cancer: Update of the EORTC QLQ-H&N Module, Phase IIISusanne Singer, Cláudia Araújo, Juan Ignacio Arraras, et al.The Journal of Dermatological Treatment|July 15, 2026
Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trialsYan Zhao, Furen Zhang, Bin Yang, et al.European Journal of Cancer (Oxford, England : 1990)|October 15, 2024
The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important changeSusanne Singer, Eva Hammerlid, Iwona M Tomaszewska, et al.Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|July 17, 2021
Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scaleSusanne Singer, Eva Hammerlid, Iwona M Tomaszewska, et al.Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi = Zhonghua Shiyan He Linchuang Bingduxue Zazhi = Chinese Journal of Experimental and Clinical Virology|November 2, 2005
[A field trial for evaluating the safety of recombinant human interferon alpha-2b for nasal spray]Qing Chen, Li-lan Zhang, De-xian Yu, et al.European Journal of Cancer (Oxford, England : 1990)|June 25, 2018
The EORTC CAT Core-The computer adaptive version of the EORTC QLQ-C30 questionnaireMorten Aa Petersen, Neil K Aaronson, Juan I Arraras, et al.The Journal of Allergy and Clinical Immunology|October 6, 2010
A trial of clarithromycin for the treatment of suboptimally controlled asthmaE Rand Sutherland, Tonya S King, Nikolina Icitovic, et al.Head & Neck|January 13, 2019
International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IVSusanne Singer, Cecilie Delphin Amdal, Eva Hammerlid, et al.Breast (Edinburgh, Scotland)|February 13, 2025
An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42Vesna Bjelic-Radisic, Fatima Cardoso, Joachim Weis, et al.Pageof 120